Intracardiac basic fibroblast growth factor and transforming growth factor-beta 1 mRNA and their proteins expression level in patients with pressure or volume-overload right or left ventricular hypertrophy

Acta Cardiologica

Volumn 60, Issue 1, 2005, Pages 21-25

  He, Zuo Yun ^a   Feng, Bing ^a   Yang, Sheng Li ^a   Luo, Hui Lan ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Basic fibroblast growth factor (bFGF); Cardiac hypertrophy; Pressure overload; Transforming growth factor beta 1 (TGF beta 1); Volume overload

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COLLAGEN TYPE 1; COLLAGEN TYPE 3; EOSIN; HEMATOXYLIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR 2; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ADULT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXTRACELLULAR MATRIX; HEART AFTERLOAD; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART PRELOAD; HEART RIGHT VENTRICLE HYPERTROPHY; HEMODYNAMICS; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PROTEIN EXPRESSION; SCHOOL CHILD; BLOOD ANALYSIS; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION TEST; HEART VENTRICLE PRESSURE; HOSPITALIZATION; MALE; METABOLISM; NEEDLE BIOPSY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; BLOOD CHEMICAL ANALYSIS; CHILD; COHORT STUDIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FIBROBLAST GROWTH FACTOR 2; HEART FUNCTION TESTS; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PROGNOSIS; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VENTRICULAR PRESSURE;

EID: 17944383424     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.60.1.2005044     Document Type: Article

References (25)

1. Roerts R, Schwartz K. Myocardial diseases. Circulation 2000; 102: IV-34-IV-39.
2. Intengan HD, Schiffrin EL. Structure and mechanical properties of resistance arteries in hypertension. Role of adhesion molecules and extracellular matrix determinants. Hypertension 2000; 36: 312-8.
3. Hautala N, Tokola H, Luodonpaa M, Puhakka J, Romppanen H, Vuolteenaho O, Ruskoaho H. Pressure overload increases GATA4 binding activity via endothelin-1. Circulation 2001; 103: 730-5.
4. He ZY, Feng B, Zhou XB, Qin J, Wen F. Change of intracardiac bFGF and RAS and its significance in course of acute pressure overload. Chin J Cardiol 1999; 27: 64-7.
5. Yamamoto K, Dang QN, Maeda Y, Huang H, Kelly RA, Lee RT. Regulation of cardiomyocyte mechanotransduction by the cardiac cycle. Circulation 2001; 103: 1459-64.
6. Molkentin JD. Calcineurin and beyond. Cardiac hypertrophic signaling. Circ Res 2000; 87: 731-8.
7. Wang F, Seta Y, Baumgarten G, Engel D J, Sivasubramanian N, Mann DL. Functional significance of hemodynamic overload-induced expression of leukemia-inhibitory factor in the adult mammalian heart. Circulation 2001; 103: 1296-302.
8. Myerson SG, Montgomery HE, Whittingham M, Jubb M, World MJ, Humphries SE, Pennell DJ. Left ventricular hypertrophy with exercise and ACE gene insertion/deletion polymorphism. A randomized controlled trial with losartan. Circulation 2001; 103: 226-30.
9. Sundstrom J, Lind L, Vessby B, Andrén B, Aro A, Lithell HO. Dyslipidemia and an unfavorable fatty acid profile predict left ventricular hypertrophy 20 years later. Circulation 2001; 103: 836-41.
10. Wesselman JP, Dobrian AD, Schriver SD, Prewitt RL. Src tyrosine kinases and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases mediate pressure-induced c-fos expression in cannulated rat mesenteric small arteries. Hypertension 2001; 37: 955-60.
11. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2000; 284(23): 3043-5.
12. Pathak M, Sarkar S, Vellaichamy E, Sen S. Role of myocytes in myocardial collagen production. Hypertension 2001; 37: 833-40.
13. Peterson JT, Hallak H, Johnson L, Li H, O'Brien PM, Sliskovic DR, Bocan TM, Coker ML, Etoh T, Spinale FG. Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure. Circulation 2001; 103: 2303-9.
14. Wen Y, Gu JL, Liu Y, Wang PH, Sun Y, Nadler JL. Nadler. Overexpression of 12-lipoxygenase causes cardiac fibroblast cell growth. Circ Res 2001; 88: 70-6.
15. Kozakova M, Galetta F, Gregorini L, Bigalli G, Franzoni F, Giusti C. Coronary vasodilator capacity and epicardial vessel remodeling in physiological and hypertensive hypertrophy. Hypertension 2000; 36: 343-9.
16. Feng J, Schaus BJ, Fallavollita JA, Lee TC, Jr JM. Preload induces troponin I degradation independently of myocardial ischemia. Circulation 2001; 103: 2035-37.
17. Raij L. Hypertension and cardiovascular risk factors. Role of the angiotensin II-nitric oxide interaction. Hypertension. 2001; 37: 767-73.
18. Weber KT. Targeting pathological remodeling. Concepts of cardioprotection and reparation. Circulation 2000; 102: 1342-5.
19. Schultz JE, Witt SA, Nieman ML, Reiser PJ, Engle SJ, Zhou M, Pawlowski SA, Lorenz JN, Kimball TR, Doetschman T. Reduction in left ventricular messenger RNA for transforming growth factor β1 attenuates left ventricular fibrosis and improves survival without lowering blood pressure in the hypertensive TGR(mRen2)27 rat. Hypertension 2000; 36: 747-54.
20. Manning BS, Shotwell K, Mao L, Rockman HA, Koch WJ. Physiological induction of a β-adrenergic responsiveness in pressure-overload cardiac hypertrophy. Circulation 2000; 102; 2751-7.
21. Mayet J, Ariff B, Wasan B, Chapman N, Shahi M, Poulter NR, Sever PS, Foale RA, Thom SA. Improvement in midwall myocardial shortening with regression of left ventricular hypertrophy. Hypertension 2000; 34: 755-9.
22. Perlini S, Muiesan ML, Cuspidi C, Sampieri L, Trimarco B, Aurigemma GP, Agabiti-Rosei E, Mancia G. Midwall mechanics are improved after regression of hypertensive left ventricular hypertrophy and normalization of chamber geometry. Circulation 103: 678-83.
23. Meyer TE, Chung ES, Perlini S, Norton GR, Woodiwiss AJ, Lorbar M, Fenton RA, Dobson JG. Antiadrenergic effects of adenosine in pressure overload hypertrophy. Hypertension 2001; 37: 862-8.
24. Nagueh SF, Stetson SJ, Lakkis NM, Killip D, Perez-Verdia A, Entman ML, Spencer WH 3rd, Torre-Amione G. Decreased expression of tumor necrosis factor-αand regression of hypertrophy after nonsurgical septal reduction therapy for patients with hypertrophic obstructive cardiomyopathy. Circulation 2001; 103: 1844-50.
25. Koide M, Hamawaki M, Narishige T, Sato H, Nemoto S, DeFreyte G, Zile MR, Cooper G IV, Carabello BA. Microtubule depolymerization normalizes in vivo myocardial contractile function in dogs with pressure-overload left ventricular hypertrophy. Circulation 2000; 102: 1045-52.